ADARx Pharmaceuticals, Inc. (ADRX) vs Enerpac Tool Group Corp. (EPAC)

A side-by-side comparison of ADARx Pharmaceuticals, Inc. and Enerpac Tool Group Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADRX

ADARx Pharmaceuticals, Inc.

$1.95B

$19.05IndustrialsDelayed quote: Oct 5, 2026, 4:00 PM EDT

EPAC

Enerpac Tool Group Corp.

$1.86B

$36.02IndustrialsDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ADRX vs EPAC

growth of $100 · dividends reinvested · last 1y

ADRX -1.6% (-1.6%/yr)EPAC +0.5% (+0.5%/yr)EPAC compounded faster over this window

ADRX EPAC

Metrics side by side

Total return (annualized)

Metric	ADRX	EPAC
Total return (1Y)	N/A	-12.64%
Total return CAGR (3Y)	N/A	9.95%
Total return CAGR (5Y)	N/A	10.86%
Total return CAGR (10Y)	N/A	4.58%

ADRX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ADRX analysis Full EPAC analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.